Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. - Wikidata - awgldk - TriplyDB

Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.

Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.

http://www.wikidata.org/entity/Q36379588

about

Prevention and Control of Antimicrobial Resistant Healthcare-Associated Infections: The Microbiology Laboratory Rocks!Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options Challenges Associated With Using Large Data Sets for Quality Assessment and Research in Clinical Settings.Incremental cost of nosocomial bacteremia according to the focus of infection and antibiotic sensitivity of the causative microorganism in a university hospital.High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting.Antibacterial resistance in sub-Saharan Africa: an underestimated emergency.Utility of Electronic Medical Records to Assess the Relationship Between Parenteral Nutrition and Central Line-Associated Bloodstream Infections in Adult Hospitalized Patients.The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control study Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program.Photodynamic UVA-riboflavin bacterial elimination in antibiotic-resistant bacteria.Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona.Prevalence of Device-associated Nosocomial Infections Caused By Gram-negative Bacteria in a Trauma Intensive Care Unit in Libya.Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients.Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis.Phase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis The Norwood operation: Relative effects of surgeon and institutional volumes on outcomes and resource utilization Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.Carbapenem Restriction and its Effect on Bacterial Resistance in an Intensive Care unit of a Teaching Hospital.Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis.A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence.The changing microbiologic epidemiology of community-acquired pneumonia.Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.Assessing Intensity of Nursing Care Needs Using Electronically Available Data.Influences on independent nurse prescribers' antimicrobial prescribing behaviour: a systematic review.Hospitalizations due to selected infections caused by opportunistic premise plumbing pathogens (OPPP) and reported drug resistance in the United States older adult population in 1991-2006.Burden of antimicrobial resistance in an era of decreasing susceptibility.Evaluation of a Computerized Decision Support Intervention to Decrease Use of Anti-Pseudomonal Carbapenems in Penicillin Allergic Patients.Trends in mortality, length of stay, and hospital charges associated with health care-associated infections, 2006-2012.Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population.The Uses and Limitations of a Hand-held Germicidal Ultraviolet Wand for Surface Disinfection.Impact on morbidity, mortality and length of stay of hospital acquired infections by resistant microorganisms.Changes in bacterial epidemiology and antibiotic resistance among veterans with spinal cord injury/disorder over the past 9 years.Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria.Anti-infective Acquisition Costs for a Stewardship Program: Getting to the Bottom Line.A sustained endemic outbreak of vancomycin-resistant Enterococcus faecium: A 30-month surveillance study.Surveillance of Antibiotic Use and Resistance in Intensive Care Units (SARI).The antibiotic resistome and microbiota landscape of refugees from Syria, Iraq and Afghanistan in Germany.

P2860

Q26745072-2EB94786-DD28-41E9-9035-C233AB75D9AC Q27015109-0DA86289-7E2F-45AB-ADE6-D19337BA89C6 Q30992278-E5C296A9-2FA0-48D1-8B09-09BBE3EDC0D0 Q33627069-B1BAE750-0C5B-495F-99DB-F6C29236FBD2 Q33630568-F5A0680F-2DA3-4FDF-999E-67268386257D Q34156590-4853E120-79DD-4192-A2E9-CA47001E0530 Q34633208-FF5BFE56-4621-41E2-AEEF-F255B30830CF Q35047983-9F1F765B-F838-4BC5-B3C6-B7F6E24D1849 Q35181034-1DF209B5-5AD1-44D5-A541-72CFBA87BB45 Q35921244-2879A971-BA18-4549-8968-96A9036B7AC1 Q35982731-9BED6527-7F4F-4E87-BCB9-7870B09EC38A Q36033050-A7BB955C-A0E1-402B-AB70-4C33599E47BF Q36048603-0D0D9960-9EDB-470F-8021-E11B54D5CB98 Q36186175-BC2620EF-AEB7-46DB-A037-19513BAFC1B3 Q36372619-284B4DA3-0532-49D6-B250-FE816A0E20A2 Q36464098-94D5EE56-659B-4EB0-AF48-7937D7156163 Q37203845-C128485B-8376-4D26-B866-08A07B1F598C Q37268544-0E5DD406-C839-460D-BE73-A6D2C4EC5983 Q37538654-6FC62686-8454-4054-907E-21D8B2BDBBB2 Q37706631-892D11BE-72CE-49D7-915F-EBE6AFD07596 Q37734003-3F43F82F-7FE3-46D0-BB0B-5EF1B7F95CDD Q38160635-560E055B-420E-4CFD-914E-EBA633CD1073 Q38165810-C2EEBA00-2078-48E7-A893-3C3AD7473D3D Q38686437-C0293A91-C510-4206-9E91-E1210D9D60F3 Q38779993-7C597E71-971C-4FED-8171-1E9857CCEDBE Q38959225-E3DEA068-D3A5-4CF4-8C23-4ED6484C6D45 Q39350575-C38232C4-8AB2-40DE-A212-160EF21A01EF Q39594331-EFDAE3BD-7246-4BD9-93C6-5DC58C457AA4 Q39748531-D4345370-9C77-4601-BC81-9FB335B799DC Q39905753-FFABBF25-5969-4C93-AE71-D2B44A188BDC Q40117928-B232AD47-1D7B-44AC-A8D7-13C4A58A030B Q40174417-F613C9D9-E82A-469E-812C-F05D0ADF2DFF Q40226218-3975914B-38E5-4335-9D04-ECEF3EC658D4 Q40332697-AA01C29A-0903-4604-A6C1-7A54181C2BAB Q40403794-940440C1-7EA7-4577-965A-DB46EFA17791 Q40433736-A914DCA2-E174-4CC3-93C0-504BE6A6BC7D Q41987292-55016FE9-7094-46D9-9877-6550E6581CDB Q42215083-B25E3C32-430E-444B-A69E-8DA7C0A7D2FA Q47260571-6C5A83C3-0B2E-4AE4-BC81-DD135727A9DA Q49843019-1C1E8C2B-927C-41EC-B6CE-D89A6F961135

P2860

Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.

http://www.wikidata.org/entity/Q36379588

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Costs of healthcare- and commu ...... crobial-susceptible organisms.

@ast

Costs of healthcare- and commu ...... crobial-susceptible organisms.

@en

type

label

Costs of healthcare- and commu ...... crobial-susceptible organisms.

@ast

Costs of healthcare- and commu ...... crobial-susceptible organisms.

@en

prefLabel

Costs of healthcare- and commu ...... crobial-susceptible organisms.

@ast

Costs of healthcare- and commu ...... crobial-susceptible organisms.

@en

P1433

Q36379588-AAE88A57-88DB-48F7-AB6F-012F49503FA0

P1476

Q36379588-D8D3EAF5-F015-4EEB-89D4-683508771B37

P2093

Q36379588-28AC1DAB-7AF8-4EFD-AC2F-4103D0E31543

Q36379588-3421007D-3038-4673-BB7B-75CFCBAD1232

Q36379588-5CF0D213-FB8E-4EC4-BB32-29FC1C10D2E5

Q36379588-6CCD5288-8FD4-4F89-9B28-78FCC82CDB11

Q36379588-8E0D7D21-9783-4E9C-94C3-DD3E11B3A555

Q36379588-F5C646B0-2612-4A3D-B956-221EFE1FC2F3

Q36379588-FA9F0CC6-1587-416B-9758-9E4EEEB30E98

P2860

Q36379588-02267088-C95F-4841-BF2C-2A49E4AFCFC7

Q36379588-080EE265-0427-4ECA-8F1C-A90715626187

Q36379588-09FCC06B-46F7-4F97-ABE1-2CC5165F66D8

Q36379588-0A218F72-E2BF-4DD0-A211-6D0CEF308B16

Q36379588-0D040F68-E843-4BDB-813C-58E34B9ABBDA

Q36379588-12B62DEA-4CA5-4BE7-B9BC-DF1948A51F38

Q36379588-1A3626C7-C43A-402B-A3CF-3FC8D8ED2C49

Q36379588-2C097D3F-3575-42D9-B2A8-BA490BBB05DC

Q36379588-38A26E87-CC83-4DBA-ACEB-CDBED5D922CE

Q36379588-3C2B4022-01E0-444E-94DC-3097F5FE99F3

P304

Q36379588-FFEBBDFF-F14A-4B54-93A6-B72308E17763

P31

Q36379588-E357905E-4177-4B25-9291-DB096302B266

P356

Q36379588-77EBBD3D-E4B2-465C-B57E-91A61635B5A5

P407

Q36379588-E3864BCC-6E81-4D8F-A39A-4D02FE7500AF

P433

Q36379588-F366A06E-2616-43B9-80BC-8473A18B4999

P478

Q36379588-08C01C4C-1881-428A-824B-DB276CB5B6AB

P577

Q36379588-9E7D2AD3-63A6-474B-9B7F-AEBA05D4961C

P5875

Q36379588-05792E66-A253-4835-AAC4-7E93EBF576DC

P698

Q36379588-CA89E234-8090-4CAC-8982-ED746AC37FA4

P921

Q36379588-BC37A9FA-8E1F-475F-9926-A5E5BC796BEB

P932

Q36379588-6CF0AAA9-5F49-4AEE-BF75-587C6DB89612

P356

P1433

Clinical Infectious Diseases

P1476

Costs of healthcare- and commu ...... crobial-susceptible organisms.

@en

P2093

Bevin Cohen

http://www.w3.org/2001/XMLSchema#string

Christie Y Jeon

http://www.w3.org/2001/XMLSchema#string

Elaine L Larson

http://www.w3.org/2001/XMLSchema#string

Jennifer Hill

http://www.w3.org/2001/XMLSchema#string

Matthew J Neidell

http://www.w3.org/2001/XMLSchema#string

Sherry Glied

http://www.w3.org/2001/XMLSchema#string

Yoko Furuya

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review.

A comparison of methods to detect urinary tract infections using electronic data.

CMS changes in reimbursement for HAIs: setting a research agenda.

Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review.

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009.

Using electronically available inpatient hospital data for research.

Factors associated with variation in estimates of the cost of resistant infections

P304

807-815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS552

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225375598

http://www.w3.org/2001/XMLSchema#string

P698

22700828

http://www.w3.org/2001/XMLSchema#string

P921

antimicrobial resistance

P932

3491852

http://www.w3.org/2001/XMLSchema#string